ArticleThe oncologist2021

Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis C Virus Infection.

Akram Alkrekshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.